CBD Life Sciences Inc. (CBDL)
OTCMKTS
· Delayed Price · Currency is USD
0.0004
+0.0001 (14.29%)
Apr 23, 2025, 3:57 PM EDT
CBD Life Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2017 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2017 - 2018 |
| Cash & Equivalents | 0 | 0 | 0 | 1.03 | - | 0.03 | Upgrade
|
| Cash & Short-Term Investments | 0 | 0 | 0 | 1.03 | 0 | 0.03 | Upgrade
|
| Cash Growth | -99.97% | 350.90% | -99.95% | 25862.97% | -86.36% | 11729.39% | Upgrade
|
| Receivables | 0.18 | - | - | - | - | - | Upgrade
|
| Inventory | 0.01 | 0.02 | 0.01 | 0.05 | - | 0.13 | Upgrade
|
| Total Current Assets | 0.19 | 0.02 | 0.01 | 1.07 | - | 0.16 | Upgrade
|
| Property, Plant & Equipment | 0.07 | 0.09 | 0.16 | 0.19 | - | - | Upgrade
|
| Goodwill | 0.1 | 0.1 | 0.1 | 0.1 | - | 1.34 | Upgrade
|
| Other Intangible Assets | 0.02 | 0.03 | 0.03 | - | - | - | Upgrade
|
| Other Long-Term Assets | 0 | 0 | 0 | 0 | - | - | Upgrade
|
| Total Assets | 0.39 | 0.24 | 0.3 | 1.36 | - | 1.49 | Upgrade
|
| Accounts Payable | - | - | - | - | - | 0.03 | Upgrade
|
| Accrued Expenses | 0.02 | 0.02 | - | - | - | - | Upgrade
|
| Other Current Liabilities | 0.02 | 0.18 | 0.17 | - | - | - | Upgrade
|
| Total Current Liabilities | 0.04 | 0.2 | 0.17 | - | - | 0.03 | Upgrade
|
| Long-Term Debt | - | - | - | - | - | 0.43 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 0.03 | - | - | Upgrade
|
| Total Liabilities | 0.04 | 0.2 | 0.17 | 0.03 | - | 0.46 | Upgrade
|
| Common Stock | 4.07 | 4.07 | 4.07 | 4.07 | - | 0.42 | Upgrade
|
| Additional Paid-In Capital | 10.82 | 10.48 | 10.48 | 10.82 | - | 6.39 | Upgrade
|
| Retained Earnings | -14.61 | -14.56 | -14.48 | -13.62 | - | -5.79 | Upgrade
|
| Comprehensive Income & Other | - | -0.01 | - | - | - | - | Upgrade
|
| Total Common Equity | 0.28 | -0.02 | 0.07 | 1.27 | -0.08 | 1.02 | Upgrade
|
| Shareholders' Equity | 0.34 | 0.04 | 0.13 | 1.33 | -0.01 | 1.03 | Upgrade
|
| Total Liabilities & Equity | 0.39 | 0.24 | 0.3 | 1.36 | - | 1.49 | Upgrade
|
| Total Debt | - | - | - | - | - | 0.43 | Upgrade
|
| Net Cash (Debt) | 0 | 0 | 0 | 1.03 | 0 | -0.4 | Upgrade
|
| Net Cash Growth | -99.97% | 350.90% | -99.95% | 25862.97% | - | - | Upgrade
|
| Net Cash Per Share | - | 0.00 | - | 0.01 | 0.00 | -0.29 | Upgrade
|
| Filing Date Shares Outstanding | 141.69 | 141.69 | 135.69 | 135.69 | 3.12 | 1.38 | Upgrade
|
| Total Common Shares Outstanding | 141.69 | 141.69 | 135.69 | 135.69 | 3.12 | 1.38 | Upgrade
|
| Working Capital | 0.14 | -0.18 | -0.16 | 1.07 | - | 0.12 | Upgrade
|
| Book Value Per Share | 0.00 | -0.00 | 0.00 | 0.01 | -0.02 | 0.73 | Upgrade
|
| Tangible Book Value | 0.15 | -0.15 | -0.06 | 1.17 | -0.18 | -0.32 | Upgrade
|
| Tangible Book Value Per Share | 0.00 | -0.00 | -0.00 | 0.01 | -0.05 | -0.23 | Upgrade
|
| Machinery | - | - | - | 0.01 | - | - | Upgrade
|
| Leasehold Improvements | - | - | - | 0.15 | - | - | Upgrade
|
Updated Jun 5, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.